EX-99.1 2 xene-ex991_48.htm EX-99.1 xene-ex991_48.htm

Exhibit 99.1

Craig Colosso

Relationship Management

 

American Stock Transfer & Trust Company, LLC
Brooklyn, NY
Office: 718.921.8337
E-mail: ccolosso@astfinancial.com

 

 

 

 

March 11, 2020

 

 

Alberta Securities Commission

British Columbia Securities Commission

Ontario Securities Commission

 

RE: Xenon Pharmaceuticals Inc.

 

Pursuant to a request from the above-mentioned reporting issuer, we wish to advise you of the following information in connection with its Annual Meeting of Shareholders:

 

Date of meeting:

June 1, 2020

Record date for notice:

April 6, 2020

Record date for voting:

April 6, 2020

Beneficial ownership determination date:

April 6, 2020

Securities entitled to notice:

Common Shares and

Series 1 Preferred Shares

Securities entitled to vote:

Common Shares and Series 1 Preferred

Shares

Issuer mailing directly to non objecting beneficial owners:

No

Issuer will pay for objecting beneficial owner material distribution:

Yes

Issuer using notice-and-access for registered investors:

No

Issuer using notice-and-access for non-registered investors:

No

Notice-and-access stratification criteria:

N/A

 

 

Yours very truly,

 

/s/ Craig Colosso

 

 

Craig Colosso

Relationship Manager

American Stock Transfer & Trust Company, LLC